PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24724F0045Pylarify qty 80 — Progenics Pharmaceuticals Inc

Progenics Pharmaceuticals Inc holds $95.0M across 149 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79719D0170. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Oct 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

247-Network Contract Office 7 (36C247)

Awarding office

Progenics Pharmaceuticals Inc

Recipient

Oct 31, 2027

PoP end

$2.7M

Obligated

$2.7M

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36C24724F0045

Also listed as36C247-24-F-0045

Also listed as36F79719D0170-36C24724F0045

Agency247-Network Contract Office 7 (36C247)

Awarding office247-Network Contract Office 7 (36C247)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentProgenics Pharmaceuticals Inc

CAGE34KE9

UEIYLYKVRPCTCR3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79719D0170

Place of performanceNORTH BILLERICA MA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startNov 1, 2023

PoP end (current)Oct 31, 2027

PoP end (w/ options)Oct 31, 2028

Obligated$2.7M

Current value$2.7M

Potential value$2.7M

Pylarify Qty 80 is a federal award for 247-Network Contract Office 7 (36C247) held by Progenics Pharmaceuticals Inc. Estimated value $2.7M ($2.7M obligated). Current period of performance ends Oct 31, 2027 (potential Oct 31, 2028). Last award drew 1 bidder. Place of performance: NORTH BILLERICA MA.

Pylarify qty 80. Latest action is a modification.

Recompete timing

Public

● Expiring in 374 days

Current PoP ends Oct 31, 2027 (374 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Want the durability read on 36C24724F0045? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Progenics Pharmaceuticals Inc — $95.0M obligated across 149 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($95.0M) · all agencies

Department of Veterans Affairs (VA)$93.8M · 99%Department of Health and Human Services (HHS)$1.1M · 1%Department of Defense (DOD)$105K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C26226F0051

PIFLUFOLASTAT F 18 - PYLARIFY

$1.1M

Oct 31, 2026

36C24926N0218

PYLARIFY PET RADIOPHARMACEUTICAL ORDERING PERIOD 3

$966K

Oct 31, 2026

36C26026F0298

PYLARIFY (PIFLUFOLASTAT F 18) INJECTIONS

$469K

Oct 31, 2026

36C24125F0139

PYLARIFY

$1.3M

Nov 30, 2026

36C24626N0284

F 18 PYLARIFY RADIOPHARMACEUTICAL. BASE IDIQ CONTRACT.

$1.5M

Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24724F0045?

36C24724F0045 (Pylarify qty 80) is a 247-Network Contract Office 7 (36C247) award with a potential value of $2.7M, currently held by Progenics Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C247-24-F-0045?

36C247-24-F-0045 is the dashed form of PIID 36C24724F0045 (Pylarify qty 80), held by Progenics Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24724F0045?

247-Network Contract Office 7 (36C247) awarded 36C24724F0045 to Progenics Pharmaceuticals Inc (potential $2.7M).

Who is the incumbent on 36C24724F0045?

Progenics Pharmaceuticals Inc is the incumbent with $95.0M across 149 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2027.

When does Progenics Pharmaceuticals Inc’s 36C24724F0045 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24724F0045? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Oct 1, 2026